{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:41:11Z","timestamp":1756464071365,"version":"3.40.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Background <jats:italic>Stenotrophomonas maltophilia<\/jats:italic> has increasingly become a significant hospital-acquired pathogen due to its multi-resistance and ability to colonize surfaces. While ocular infections caused by <jats:italic>S. maltophilia<\/jats:italic> are documented, endogenous endophthalmitis (EE) is rare with only six cases reported in adults, mostly in immunocompromised individuals from developing countries. Here, we present the first documented case of <jats:italic>S. maltophilia<\/jats:italic>-associated EE in an immunocompetent adult in Australia. A 43-year-old female presented with a two-day history of painful vision loss in her left eye. There was no preceding trauma, systemic illness, or history of intravenous drug use. Notably, she worked as a marine biology researcher and had recently been visiting the hospital often to see family. Examination revealed severe anterior chamber inflammation, hypopyon, and vitritis. Initial treatment included hourly dexamethasone 0.1% eye drops while awake, atropine 1% three times daily, a single vitreous tap, and injection of intravitreal vancomycin (1\u00a0mg\/0.1mL), ceftazidime (2.25\u00a0mg\/0.1mL), and voriconazole (0.05\u00a0mg\/0.1mL). Cultures confirmed <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>, and oral trimethoprim-sulfamethoxazole (160\u00a0mg\/800\u00a0mg) 1.5 tabs three times daily was initiated but later switched to moxifloxacin 400\u00a0mg daily due to neutropenia. One-month post-discharge, the patient developed an inferior retinal detachment requiring vitrectomy with silicone oil. At six months, her visual acuity improved to 6\/18.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\n              <jats:italic>S. maltophilia<\/jats:italic>-associated EE is a rare clinical condition, especially in the absence of systemic symptoms. Despite the poor prognosis typically associated with endophthalmitis, this case resulted in a relatively good visual outcome (BCVA 6\/18). This report highlights the necessity for further research to elucidate the epidemiology, risk factors, and optimal management strategies for this rare ocular condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12886-025-03990-4","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:40:13Z","timestamp":1743234013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stenotrophomonas maltophilia endogenous endophthalmitis in an immunocompetent eye in Australia"],"prefix":"10.1186","volume":"25","author":[{"given":"Cadric","family":"Gunaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ario A.","family":"Wilson-Pogmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travers","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"1","key":"3990_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","volume":"25","author":"JS Brooke","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2\u201341.","journal-title":"Clin Microbiol Rev"},{"issue":"null","key":"3990_CR2","first-page":"1523","volume":"8","author":"J Chhablani","year":"2014","unstructured":"Chhablani J, Sudhalkar A, Jindal A, Das T, Motukupally SR, Sharma S, et al. Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, antibiotic susceptibility, and outcomes. Clin Ophthalmol. 2014;8(null):1523\u20136.","journal-title":"Clin Ophthalmol"},{"issue":"Pt 6","key":"3990_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1099\/jmm.0.009431-0","volume":"58","author":"T Das","year":"2009","unstructured":"Das T, Deshmukh HS, Mathai A, Reddy AK. Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, sensitivity spectrum and management. J Med Microbiol. 2009;58(Pt 6):837\u20138.","journal-title":"J Med Microbiol"},{"key":"3990_CR4","doi-asserted-by":"crossref","unstructured":"Suhan D, Kolavali RR, Kelgaonkar A. Sieve-like preretinal exudates in Stenotrophomonas maltophilia endogenous endophthalmitis. BMJ Case Rep. 2021;14(7):e244392.","DOI":"10.1136\/bcr-2021-244392"},{"issue":"8","key":"3990_CR5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/IAE.0000000000003168","volume":"41","author":"A Bilgic","year":"2021","unstructured":"Bilgic A, Sudhalkar A, Gonzalez-Cortes JH, March de Ribot F, Yogi R, Kodjikian L, et al. ENDOGENOUS ENDOPHTHALMITIS IN THE SETTING OF COVID-19 INFECTION: A Case Series. Retina. 2021;41(8):1709\u201314.","journal-title":"Retina"},{"issue":"1","key":"3990_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12348-023-00368-9","volume":"13","author":"B Tar\u0131m","year":"2023","unstructured":"Tar\u0131m B, Yorgun MA, \u00d6zdem B, Ak\u00e7ay EK. Stenotrophomonas maltophilia endophthalmitis following keratoplasty. J Ophthalmic Inflamm Infect. 2023;13(1):46.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"6","key":"3990_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4103\/ijo.IJO_710_18","volume":"67","author":"A Maitray","year":"2019","unstructured":"Maitray A, Rishi E, Rishi P, Gopal L, Bhende P, Ray R, et al. Endogenous endophthalmitis in children and adolescents: Case series and literature review. Indian J Ophthalmol. 2019;67(6):795\u2013800.","journal-title":"Indian J Ophthalmol"},{"key":"3990_CR8","doi-asserted-by":"crossref","unstructured":"Mojica MF, Humphries R, Lipuma JJ, Mathers AJ, Rao GG, Shelburne SA et al. Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC-Antimicrobial Resist. 2022;4(3):dlac040.","DOI":"10.1093\/jacamr\/dlac040"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03990-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03990-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03990-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:40:39Z","timestamp":1743234039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03990-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3990"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03990-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}